Cargando…

Non-Invasive Targeted Peripheral Nerve Ablation Using 3D MR Neurography and MRI-Guided High-Intensity Focused Ultrasound (MR-HIFU): Pilot Study in a Swine Model

PURPOSE: Ultrasound (US)-guided high intensity focused ultrasound (HIFU) has been proposed for noninvasive treatment of neuropathic pain and has been investigated in in-vivo studies. However, ultrasound has important limitations regarding treatment guidance and temperature monitoring. Magnetic reson...

Descripción completa

Detalles Bibliográficos
Autores principales: Huisman, Merel, Staruch, Robert M., Ladouceur-Wodzak, Michelle, van den Bosch, Maurice A., Burns, Dennis K., Chhabra, Avneesh, Chopra, Rajiv
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4682836/
https://www.ncbi.nlm.nih.gov/pubmed/26659073
http://dx.doi.org/10.1371/journal.pone.0144742
_version_ 1782405931958534144
author Huisman, Merel
Staruch, Robert M.
Ladouceur-Wodzak, Michelle
van den Bosch, Maurice A.
Burns, Dennis K.
Chhabra, Avneesh
Chopra, Rajiv
author_facet Huisman, Merel
Staruch, Robert M.
Ladouceur-Wodzak, Michelle
van den Bosch, Maurice A.
Burns, Dennis K.
Chhabra, Avneesh
Chopra, Rajiv
author_sort Huisman, Merel
collection PubMed
description PURPOSE: Ultrasound (US)-guided high intensity focused ultrasound (HIFU) has been proposed for noninvasive treatment of neuropathic pain and has been investigated in in-vivo studies. However, ultrasound has important limitations regarding treatment guidance and temperature monitoring. Magnetic resonance (MR)-imaging guidance may overcome these limitations and MR-guided HIFU (MR-HIFU) has been used successfully for other clinical indications. The primary purpose of this study was to evaluate the feasibility of utilizing 3D MR neurography to identify and guide ablation of peripheral nerves using a clinical MR-HIFU system. METHODS: Volumetric MR-HIFU was used to induce lesions in the peripheral nerves of the lower limbs in three pigs. Diffusion-prep MR neurography and T1-weighted images were utilized to identify the target, plan treatment and immediate post-treatment evaluation. For each treatment, one 8 or 12 mm diameter treatment cell was used (sonication duration 20 s and 36 s, power 160–300 W). Peripheral nerves were extracted < 3 hours after treatment. Ablation dimensions were calculated from thermal maps, post-contrast MRI and macroscopy. Histological analysis included standard H&E staining, Masson’s trichrome and toluidine blue staining. RESULTS: All targeted peripheral nerves were identifiable on MR neurography and T1-weighted images and could be accurately ablated with a single exposure of focused ultrasound, with peak temperatures of 60.3 to 85.7°C. The lesion dimensions as measured on MR neurography were similar to the lesion dimensions as measured on CE-T1, thermal dose maps, and macroscopy. Histology indicated major hyperacute peripheral nerve damage, mostly confined to the location targeted for ablation. CONCLUSION: Our preliminary results indicate that targeted peripheral nerve ablation is feasible with MR-HIFU. Diffusion-prep 3D MR neurography has potential for guiding therapy procedures where either nerve targeting or avoidance is desired, and may also have potential for post-treatment verification of thermal lesions without contrast injection.
format Online
Article
Text
id pubmed-4682836
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-46828362015-12-31 Non-Invasive Targeted Peripheral Nerve Ablation Using 3D MR Neurography and MRI-Guided High-Intensity Focused Ultrasound (MR-HIFU): Pilot Study in a Swine Model Huisman, Merel Staruch, Robert M. Ladouceur-Wodzak, Michelle van den Bosch, Maurice A. Burns, Dennis K. Chhabra, Avneesh Chopra, Rajiv PLoS One Research Article PURPOSE: Ultrasound (US)-guided high intensity focused ultrasound (HIFU) has been proposed for noninvasive treatment of neuropathic pain and has been investigated in in-vivo studies. However, ultrasound has important limitations regarding treatment guidance and temperature monitoring. Magnetic resonance (MR)-imaging guidance may overcome these limitations and MR-guided HIFU (MR-HIFU) has been used successfully for other clinical indications. The primary purpose of this study was to evaluate the feasibility of utilizing 3D MR neurography to identify and guide ablation of peripheral nerves using a clinical MR-HIFU system. METHODS: Volumetric MR-HIFU was used to induce lesions in the peripheral nerves of the lower limbs in three pigs. Diffusion-prep MR neurography and T1-weighted images were utilized to identify the target, plan treatment and immediate post-treatment evaluation. For each treatment, one 8 or 12 mm diameter treatment cell was used (sonication duration 20 s and 36 s, power 160–300 W). Peripheral nerves were extracted < 3 hours after treatment. Ablation dimensions were calculated from thermal maps, post-contrast MRI and macroscopy. Histological analysis included standard H&E staining, Masson’s trichrome and toluidine blue staining. RESULTS: All targeted peripheral nerves were identifiable on MR neurography and T1-weighted images and could be accurately ablated with a single exposure of focused ultrasound, with peak temperatures of 60.3 to 85.7°C. The lesion dimensions as measured on MR neurography were similar to the lesion dimensions as measured on CE-T1, thermal dose maps, and macroscopy. Histology indicated major hyperacute peripheral nerve damage, mostly confined to the location targeted for ablation. CONCLUSION: Our preliminary results indicate that targeted peripheral nerve ablation is feasible with MR-HIFU. Diffusion-prep 3D MR neurography has potential for guiding therapy procedures where either nerve targeting or avoidance is desired, and may also have potential for post-treatment verification of thermal lesions without contrast injection. Public Library of Science 2015-12-14 /pmc/articles/PMC4682836/ /pubmed/26659073 http://dx.doi.org/10.1371/journal.pone.0144742 Text en © 2015 Huisman et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Huisman, Merel
Staruch, Robert M.
Ladouceur-Wodzak, Michelle
van den Bosch, Maurice A.
Burns, Dennis K.
Chhabra, Avneesh
Chopra, Rajiv
Non-Invasive Targeted Peripheral Nerve Ablation Using 3D MR Neurography and MRI-Guided High-Intensity Focused Ultrasound (MR-HIFU): Pilot Study in a Swine Model
title Non-Invasive Targeted Peripheral Nerve Ablation Using 3D MR Neurography and MRI-Guided High-Intensity Focused Ultrasound (MR-HIFU): Pilot Study in a Swine Model
title_full Non-Invasive Targeted Peripheral Nerve Ablation Using 3D MR Neurography and MRI-Guided High-Intensity Focused Ultrasound (MR-HIFU): Pilot Study in a Swine Model
title_fullStr Non-Invasive Targeted Peripheral Nerve Ablation Using 3D MR Neurography and MRI-Guided High-Intensity Focused Ultrasound (MR-HIFU): Pilot Study in a Swine Model
title_full_unstemmed Non-Invasive Targeted Peripheral Nerve Ablation Using 3D MR Neurography and MRI-Guided High-Intensity Focused Ultrasound (MR-HIFU): Pilot Study in a Swine Model
title_short Non-Invasive Targeted Peripheral Nerve Ablation Using 3D MR Neurography and MRI-Guided High-Intensity Focused Ultrasound (MR-HIFU): Pilot Study in a Swine Model
title_sort non-invasive targeted peripheral nerve ablation using 3d mr neurography and mri-guided high-intensity focused ultrasound (mr-hifu): pilot study in a swine model
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4682836/
https://www.ncbi.nlm.nih.gov/pubmed/26659073
http://dx.doi.org/10.1371/journal.pone.0144742
work_keys_str_mv AT huismanmerel noninvasivetargetedperipheralnerveablationusing3dmrneurographyandmriguidedhighintensityfocusedultrasoundmrhifupilotstudyinaswinemodel
AT staruchrobertm noninvasivetargetedperipheralnerveablationusing3dmrneurographyandmriguidedhighintensityfocusedultrasoundmrhifupilotstudyinaswinemodel
AT ladouceurwodzakmichelle noninvasivetargetedperipheralnerveablationusing3dmrneurographyandmriguidedhighintensityfocusedultrasoundmrhifupilotstudyinaswinemodel
AT vandenboschmauricea noninvasivetargetedperipheralnerveablationusing3dmrneurographyandmriguidedhighintensityfocusedultrasoundmrhifupilotstudyinaswinemodel
AT burnsdennisk noninvasivetargetedperipheralnerveablationusing3dmrneurographyandmriguidedhighintensityfocusedultrasoundmrhifupilotstudyinaswinemodel
AT chhabraavneesh noninvasivetargetedperipheralnerveablationusing3dmrneurographyandmriguidedhighintensityfocusedultrasoundmrhifupilotstudyinaswinemodel
AT choprarajiv noninvasivetargetedperipheralnerveablationusing3dmrneurographyandmriguidedhighintensityfocusedultrasoundmrhifupilotstudyinaswinemodel